Sustainable aviation fuel (SAF) will play a critical role in decarbonizing the aviation industry. Among SAF production pathways, alcohol-to-jet stands out for its scalability, supported by abundant feedstock availability and a well-established bioethanol industry. However, significant reductions in SAF carbon intensity require the use of cellulosic feedstocks, whose adoption is hindered by high capital costs for feedstock processing and ethanol upgrading. A study by researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) demonstrated that leveraging established petroleum infrastructure can facilitate SAF deployment via cellulosic alcohol-to-jet coprocessing to enable cost-effective, low-carbon aviation fuels.

Researchers developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases. The study team demonstrated that this platform could reveal disease-causing genetic variants and provide molecular diagnoses for previously undiagnosed patients, including five individuals whose conditions had remained unresolved after standard testing.